Read this company snapshot
Daily valuation snapshot
Chemomab Therapeutics Ltd. American Depositary Share: source evidence dated 2026-10-09.
- Daily close (USD)
- $1.38
- Market capitalization (USD)
- $99,253,277.7
- Price / earnings (TTM)
- Not reported
- Price / book
- 3.55
The source values and product destination above identify the example to inspect.
What business is this, and what does its dated valuation mean?
Check the market day first. P/E uses trailing earnings; book value and market capitalization answer different questions.
Daily valuation dataset and column definitionsOpen the company research view or ask Aurora to reconcile reporting periods, earnings, debt and the figures behind the valuation.
Research CMMB in the app
Open the company research view or ask Aurora to reconcile reporting periods, earnings, debt and the figures behind the valuation.
Research CMMB in the appKeep reporting dates and units beside the answer, and inspect its original citations.
Company overview
Chemomab Therapeutics Ltd., a clinical-stage biotechnology company, focuses on the discovery and development of therapeutics for the treatment of fibrotic and inflammatory diseases in the United States. Its lead product candidate is Nebokitug, a humanized monoclonal antibody attenuates the basic function of CCL24 that has completed phase 2 clinical trial for the treatment of primary sclerosing cholangitis (PSC); and is in phase 2 clinical trial to treat systemic sclerosis (SSc). Chemomab Therapeutics Ltd. was founded in 2011 and is based in Tel Aviv, Israel.
Daily valuation snapshot
See the complete daily valuation snapshot
These values come from the daily market snapshot dated 2026-10-09. TTM means trailing twelve months. Use the market date when comparing CMMB with another company.
Scroll sideways to compare all columns. Select a heading to sort.
| Daily close (USD) | $1.38 |
| Market capitalization (USD) | $99,253,277.7 |
| Price / earnings (TTM) | Not reported |
| Price / book | 3.55 |
No matching rows. Clear the filter to see all records.
Read CMMB's valuation metrics
Company size
Chemomab Therapeutics Ltd. American Depositary Share's recorded market capitalization is $99,253,277.7. It measures the market value of the company's equity, rather than its revenue or cash balance.
Price relative to earnings
P/E compares share price with trailing annual earnings per share. For a company with losses, inspect the earnings figures directly rather than treating a negative multiple as a cheap valuation.
Price relative to book equity
CMMB's recorded price-to-book ratio is 3.55. That compares its market equity value with recorded book equity. Examine its business and balance sheet to understand why those values differ.
Research Chemomab Therapeutics Ltd. American Depositary Share with Aurora
Use the snapshot above to ask a specific question about CMMB. Ask for the report period and the figures behind the explanation, then compare the answer with the company's business description.
Continue the research
Follow CMMB's ownership disclosures to see who filed a transaction or position and when it became public. To turn a research idea into a strategy, define an entry rule and test its dated observations.